6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-03-24), TNF Pharmaceuticals's 6-1 Month Momentum % is -61.68%.
The industry rank for TNF Pharmaceuticals's 6-1 Month Momentum % or its related term are showing as below:
TNFA's 6-1 Month Momentum % is ranked worse than 91.35% of 1480
companies
in the Biotechnology industry
Industry Median: -9.63
vs TNFA: -61.68
Competitive Comparison of TNF Pharmaceuticals's 6-1 Month Momentum %
For the Biotechnology subindustry, TNF Pharmaceuticals's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TNF Pharmaceuticals's 6-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TNF Pharmaceuticals's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where TNF Pharmaceuticals's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
TNF Pharmaceuticals 6-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of TNF Pharmaceuticals's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TNFA has been successfully added to your